PharmX Technologies Limited (ASX:PHX)

PharmX Technologies Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 8, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	55	23	22	20	52	17
Market Cap Growth	80.49%	2.90%	8.94%	-60.92%	199.92%	125.25%
Enterprise Value	51	11	17	14	45	14
Last Close Price	0.09	0.04	0.03	0.03	0.07	0.03
PE Ratio	466.63	-	-	80.52	47.59	98.36
PS Ratio	6.38	2.81	3.61	3.77	4.37	1.63
PB Ratio	3.41	1.42	1.00	0.87	2.26	1.31
P/TBV Ratio	12.93	7.48	2.50	8.19	14.24	2.03
P/FCF Ratio	-	7.13	2.04	6.37	18.14	81.27
P/OCF Ratio	-	7.10	2.02	6.18	16.42	46.91
EV/Sales Ratio	5.88	1.31	2.78	2.65	3.78	1.34
EV/EBITDA Ratio	84.05	19.99	-	21.02	26.90	18.53
EV/EBIT Ratio	241.76	43.42	-	112.40	36.72	27.60
EV/FCF Ratio	-6.63	3.32	1.57	4.48	15.67	66.74
Debt / Equity Ratio	0.01	0.02	0.00	0.01	0.01	0.06
Debt / EBITDA Ratio	0.31	0.38	-	0.32	0.15	0.64
Debt / FCF Ratio	-	0.08	0.00	0.10	0.11	3.44
Asset Turnover	0.36	0.24	0.18	0.17	0.47	0.62
Inventory Turnover	-	-	-	85.40	173.43	135.96
Quick Ratio	5.13	1.36	1.25	1.64	1.39	1.43
Current Ratio	5.35	1.37	1.84	1.68	1.63	1.80
Return on Equity (ROE)	0.09%	0.50%	-3.89%	-0.57%	5.97%	1.55%
Return on Assets (ROA)	0.55%	0.46%	-1.23%	0.26%	3.02%	1.88%
Return on Capital (ROIC)	0.80%	0.79%	-1.82%	0.34%	4.11%	2.74%
Return on Capital Employed (ROCE)	1.20%	1.40%	-	0.50%	4.90%	3.80%
Earnings Yield	0.21%	-7.78%	-4.75%	1.24%	2.10%	1.02%
FCF Yield	-13.91%	14.02%	49.13%	15.70%	5.51%	1.23%
Payout Ratio	-	-	-	-	82.13%	-
Buyback Yield / Dilution	-1.59%	-0.17%	0.56%	-9.81%	-57.55%	-35.51%
Total Shareholder Return	-	-0.17%	0.56%	-9.81%	-57.55%	-35.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.